These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


641 related items for PubMed ID: 26235479

  • 1. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.
    Mané A, Fernández-Expósito M, Bergé D, Gómez-Pérez L, Sabaté A, Toll A, Diaz L, Diez-Aja C, Perez V.
    Psychiatry Res; 2015 Sep 30; 229(1-2):70-4. PubMed ID: 26235479
    [Abstract] [Full Text] [Related]

  • 2. Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use.
    Ruiz-Veguilla M, Gurpegui M, Barrigón ML, Ferrín M, Marín E, Rubio JL, Gutiérrez B, Pintor A, Cervilla J.
    Schizophr Res; 2009 Feb 30; 107(2-3):158-64. PubMed ID: 18805673
    [Abstract] [Full Text] [Related]

  • 3. Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation.
    Stone JM, Fisher HL, Major B, Chisholm B, Woolley J, Lawrence J, Rahaman N, Joyce J, Hinton M, Johnson S, Young AH, MiData Consortium.
    Psychol Med; 2014 Feb 30; 44(3):499-506. PubMed ID: 23701858
    [Abstract] [Full Text] [Related]

  • 4. Reasons for cannabis use: patients with schizophrenia versus matched healthy controls.
    Schaub M, Fanghaenel K, Stohler R.
    Aust N Z J Psychiatry; 2008 Dec 30; 42(12):1060-5. PubMed ID: 19016094
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Age of onset of Cannabis use and cognitive function in first-episode non-affective psychosis patients: Outcome at three-year follow-up.
    Setién-Suero E, Martínez-García O, de la Foz VO, Vázquez-Bourgon J, Correa-Ghisays P, Ferro A, Crespo-Facorro B, Ayesa-Arriola R.
    Schizophr Res; 2018 Nov 30; 201():159-166. PubMed ID: 29861266
    [Abstract] [Full Text] [Related]

  • 8. Reasons for increased substance use in psychosis.
    Gregg L, Barrowclough C, Haddock G.
    Clin Psychol Rev; 2007 May 30; 27(4):494-510. PubMed ID: 17240501
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study.
    Degenhardt L, Tennant C, Gilmour S, Schofield D, Nash L, Hall W, McKay D.
    Psychol Med; 2007 Jul 30; 37(7):927-34. PubMed ID: 17288638
    [Abstract] [Full Text] [Related]

  • 12. Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder.
    Ringen PA, Nesvåg R, Helle S, Lagerberg TV, Lange EH, Løberg EM, Agartz I, Andreassen OA, Melle I.
    Psychol Med; 2016 Nov 30; 46(15):3127-3136. PubMed ID: 27534999
    [Abstract] [Full Text] [Related]

  • 13. Delusions incorporating cannabis use in dually diagnosed patients with a primary psychotic disorder.
    Flanders SE.
    Aust N Z J Psychiatry; 2007 Nov 30; 41(11):934-6. PubMed ID: 17924247
    [Abstract] [Full Text] [Related]

  • 14. Early adolescent cannabis exposure and positive and negative dimensions of psychosis.
    Stefanis NC, Delespaul P, Henquet C, Bakoula C, Stefanis CN, Van Os J.
    Addiction; 2004 Oct 30; 99(10):1333-41. PubMed ID: 15369572
    [Abstract] [Full Text] [Related]

  • 15. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
    Rubio G, Marín-Lozano J, Ferre F, Martínez-Gras I, Rodriguez-Jimenez R, Sanz J, Jimenez-Arriero MA, Carrasco JL, Lora D, Jurado R, López-Trabada JR, Palomo T.
    Compr Psychiatry; 2012 Nov 30; 53(8):1063-70. PubMed ID: 22682680
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 33.